In this week’s View, Dr. Eagle explores longitudinal changes in pulmonary artery pressure late in life using data from the ARIC study. He then discusses the safety and tolerability of inclisiran for treatment of hypercholesterolemia. Finally, Dr. Eagle asses late gadolinium enhancement in hypertrophic cardiomyopathy and how it improves risk stratification based on current guidelines.    Subscribe to Eagle’s Eye View  

Eagle’s Eye View: What is the Safety and Tolerability of Inclisiran in Treating Hypercholesterolemia?

The weekly cardiovascular update from ACC.org Editor-in-Chief Kim Eagle, MD, MACC, covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Medicine

Science & Medicine

Health & Fitness

In this week’s View, Dr. Eagle looks at excess apolipoprotein-B and cardiovascular risk, then examines a recent meta-analysis on treating pulmonary arterial hypertension. Finally, Dr. Eagle shares some thoughts on a SMART-C collaborative meta-analysis of sodium-glucose cotransporter-2 inhibitors and major adverse cardiovascular outcomes.    Subscribe to Eagle’s Eye View  

Excess Apolipoprotein-B and Cardiovascular Risk, Treating Pulmonary Arterial Hypertension, SGLT2i and CV Outcomes

In this week’s View, Dr. Eagle looks at anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting. He then examines a meta-analysis of invasive vs. conservative management of non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting. Finally, Dr. Eagle shares some thoughts on JACC’s recent State of the Art Review of arrhythmia-induced cardiomyopathy.    Subscribe to Eagle’s Eye View  

Anticoagulation in Post-Operative AFib, Non-ST-Elevation Acute Coronary Syndromes, Arrhythmia-Induced Cardiomyopathy

In this week’s View, Dr. Eagle looks at the diagnostic value of aortic valve calcification levels in the assessment of low-gradient aortic stenosis.        He then examines the prognostic value of microvascular resistance reserve after percutaneous coronary intervention in patients with myocardial infarction.        Finally, Dr. Eagle shares some thoughts on clinical outcomes associated with various microvascular injury patterns identified by cardiac MRI after STEMI.    Subscribe to Eagle’s Eye View  

Aortic Valve Calcification and Aortic Stenosis, Microvascular Resistance Reserve After PCI, Microvascular Injury Patterns

In this week’s View, Dr. Eagle looks at transcatheter-based intervention for tetraology of Fallot. He then examines how a small left ventricle in patients with atrial fibrillation is associated with increased cardiovascular risk. Finally, Dr. Eagle shares some thoughts on an aspirin-free strategy for immediate treatment following complex percutaneous coronary intervention.    Subscribe to Eagle’s Eye View  

Transcatheter-Based Intervention and Tetralogy of Fallot, Small Left Ventricle and Atrial Fibrillation (Afib), Aspirin Free Treatment Post-PCI

In this week’s View, Dr. Eagle looks at the recently released guidelines for lower extremity peripheral arterial disease (PAD). He then examines a national community-based cohort study on contemporary decongestion strategies in patients hospitalized for heart failure. Finally, Dr. Eagle shares some thoughts on the implications of discordance among ApoB, non–high-density lipoprotein cholesterol and triglycerides for cardiovascular prevention.    Subscribe to Eagle’s Eye View  

Guideline for the Management of Lower Extremity Peripheral Artery Disease (PAD), Decongestion Strategies for Heart Failure, Lipoproteins and Triglycerides in Cardiovascular Prevention

Eagle’s Eye View: What is the Safety and Tolerability of Inclisiran in Treating Hypercholesterolemia?

Download our free app to listen on your phone